Chlorine in PDB 8hum: X-Ray Structure of Human Ppar Gamma Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Co- Crystallization

Enzymatic activity of X-Ray Structure of Human Ppar Gamma Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Co- Crystallization

All present enzymatic activity of X-Ray Structure of Human Ppar Gamma Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Co- Crystallization:
2.3.1.48;

Protein crystallography data

The structure of X-Ray Structure of Human Ppar Gamma Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Co- Crystallization, PDB code: 8hum was solved by S.Kamata, A.Honda, Y.Machida, K.Uchii, Y.Shiiyama, R.Masuda, T.Oyama, I.Ishii, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 39.27 / 2.29
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 49.862, 63.728, 123.484, 90, 90, 90
R / Rfree (%) 20.6 / 25

Chlorine Binding Sites:

The binding sites of Chlorine atom in the X-Ray Structure of Human Ppar Gamma Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Co- Crystallization (pdb code 8hum). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the X-Ray Structure of Human Ppar Gamma Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Co- Crystallization, PDB code: 8hum:

Chlorine binding site 1 out of 1 in 8hum

Go back to Chlorine Binding Sites List in 8hum
Chlorine binding site 1 out of 1 in the X-Ray Structure of Human Ppar Gamma Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Co- Crystallization


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of X-Ray Structure of Human Ppar Gamma Ligand Binding Domain- Lanifibranor-SRC1 Coactivator Peptide Co-Crystals Obtained By Co- Crystallization within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl501

b:60.8
occ:1.00
 CL1 A:BJB501 0.0 60.8 1.0
C7 A:BJB501 1.8 58.2 1.0
C8 A:BJB501 2.8 57.3 1.0
H1 A:BJB501 2.9 68.8 1.0
C6 A:BJB501 2.9 57.7 1.0
H9 A:BJB501 3.0 69.3 1.0
CD1 A:LEU356 3.6 51.0 1.0
CG2 A:ILE281 3.6 55.8 1.0
O A:PHE360 3.7 57.0 1.0
CB A:PHE360 4.0 53.4 1.0
C9 A:BJB501 4.2 60.4 1.0
C A:PHE360 4.3 57.9 1.0
CD1 A:PHE360 4.3 62.1 1.0
C4 A:BJB501 4.3 59.9 1.0
CD1 A:LEU353 4.4 50.3 1.0
CA A:PHE360 4.4 59.7 1.0
CB A:ILE281 4.4 51.2 1.0
O A:ALA278 4.5 55.8 1.0
CB A:PHE363 4.5 51.7 1.0
CG A:PHE360 4.6 64.5 1.0
N A:PHE282 4.7 50.6 1.0
CD2 A:PHE363 4.7 61.2 1.0
C5 A:BJB501 4.8 63.3 1.0
H2 A:BJB501 4.9 72.5 1.0
CG A:LEU356 4.9 53.1 1.0

Reference:

S.Kamata, A.Honda, R.Ishikawa, M.Akahane, A.Fujita, C.Kaneko, S.Miyawaki, Y.Habu, Y.Shiiyama, K.Uchii, Y.Machida, T.Oyama, I.Ishii. Functional and Structural Insights Into the Human Ppar Alpha / Delta / Gamma Targeting Preferences of Anti-Nash Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor Antioxidants V. 12 1523 2023.
ISSN: ESSN 2076-3921
DOI: 10.3390/ANTIOX12081523
Page generated: Tue Jul 30 10:23:10 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy